Clinical Trial Update: A Study of Trastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 1/2 study of trastuzumab emtansine (T-DM1) in combination with docetaxel, and potentially pertuzumab, for advanced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Kadcyla (ado-trastuzumab emtansine)
• Perjeta (pertuzumab)
• Taxotere (docetaxel)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-04-06